1. Long non-coding RNA LBX2-AS1 predicts poor survival of colon cancer patients and promotes its progression via regulating miR-627-5p/RAC1/PI3K/AKT pathway
   Jing Fang et al, 2022, Human Cell CrossRef
2. Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients
   Mingjie Yuan et al, 2022, Frontiers in Genetics CrossRef
3. Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?
   Klara Klein et al, 2021, Cancers CrossRef
4. Not Only Immune Escape—The Confusing Role of the TRP Metabolic Pathway in Carcinogenesis
   Iwona Kwiatkowska et al, 2021, Cancers CrossRef
5. Bidirectional Interaction Between Cancer Cells and Platelets Provides Potential Strategies for Cancer Therapies
   Liuting Yu et al, 2021, Frontiers in Oncology CrossRef
6. Tofacitinib Suppresses Natural Killer Cells In Vitro and In Vivo: Implications for Amyotrophic Lateral Sclerosis
   Claudia Figueroa-Romero et al, 2022, Frontiers in Immunology CrossRef
7. The role of CD56bright NK cells in neurodegenerative disorders
   Carla Rodriguez-Mogeda et al, 2024, Journal of Neuroinflammation CrossRef
8. Signal transducer and activator of transcription 6 as a target in colon cancer therapy (Review)
   Yael Delgado‑Ramirez et al, 2020, Oncology Letters CrossRef
9. Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis
   Masayoshi Harigai, 2019, Rheumatology CrossRef
10. Immunomodulatory Effect of Lactobacillus casei in a Murine Model of Colon Carcinogenesis
    Josefina Casas-Solís et al, 2020, Probiotics and Antimicrobial Proteins CrossRef
11. Emerging roles of platelets in cancer biology and their potential as therapeutic targets
    Lei Wang et al, 2022, Frontiers in Oncology CrossRef
12. Targeting the STAT6 signaling pathway as a therapy against colon cancer
    Ana Catalina Rivera Rugeles et al, 2021, Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives CrossRef
13. Cellular senescence: a view throughout organismal life
    Cayetano von Kobbe, 2018, Cellular and Molecular Life Sciences CrossRef
14. Evaluating filgotinib for the treatment of rheumatoid arthritis
    Christophe Richez et al, 2021, Expert Opinion on Pharmacotherapy CrossRef
15. Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma
    Kie Nakatani et al, 2022, Journal of Oral Pathology & Medicine CrossRef
16. Targeting T regulatory cells: Their role in colorectal carcinoma progression and current clinical trials
    Sai Samyuktha Bandaru et al, 2022, Pharmacological Research CrossRef
17. RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway
    Peifen Lu et al, 2019, Cancer Biology & Therapy CrossRef
18. Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial‑ mesenchymal transition via the AKT/GSK‑3β/Snail signaling pathway
    Li Yuan et al, 2019, Molecular Medicine Reports CrossRef
19. JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications
    Mark D Russell et al, 2023, Annals of the Rheumatic Diseases CrossRef
20. Human Cancer and Platelet Interaction, a Potential Therapeutic Target
    Shike Wang et al, 2018, International Journal of Molecular Sciences CrossRef
21. Tofacitinib for the treatment of rheumatoid arthritis: an update
    Kunihiro Yamaoka, 2019, Expert Review of Clinical Immunology CrossRef